Abstract:Objective: To analyze the pathological features of patients with osteosarcoma and the correlation of expressions of transferrin receptor 1 (TfR1), vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP)-9 in tumor tissue with the pathological features. Methods: The tumor tissue and paracancerous tissue samples from 31 patients with osteosarcoma were collected before treatment to measure the expressions of TfR1, VEGF and MMP-9. Kaplan-meier curve was used to analyze the relationship of TfR1, VEGF and MMP-9 with the survival time of patients. Log-rank test was used to test the difference, and Spearman test was used to test the correlation. Results: Among the 31 osteosarcoma samples, 23 (74.19%), 24 (77.42%) and 17 (54.84%) samples showed medium-high expressions of VEGF, TfR1 and MMP-9, respectively, which were significantly higher than those in the paracancerous samples (P<0.05). Furthemore, the medium-high expression rates of VEGF, TfR1 and MMP-9 were significantly different in patients with different Enneking stages, different histological differentiation degrees, and with or without distant metastasis. Besides, the expression of VEGF was also significantly different in different-size osteosarcoma samples (P<0.05). The survival time of patients with low expressions of TfR1, VEGF and MMP-9 was significantly longer than that of patients with medium-high expressions (P<0.05). Additionally, in osteosarcoma samples, significant positive correlations were shown between the expressions of TfR1 and VEGF, as well as between TfR1 and MMP-9 (P<0.05), but there was no significant correlation between VEGF and MMP-9 (P>0.05). Conclusion: TfR1, VEGF and MMP-9 are abnormally expressed in osteosarcoma lesions, suggesting that they all play a role in the occurrence and development of osteosarcoma.

Expressions and implication of MMP-9 and VEGF in osteosarcoma

The Expression of Vascular Endothelial Growth Factor, Matrix Metalloproteinases 2,9 in Osteosarcoma

Clinical predictive value of serum angiogenic factor in patients with osteosarcoma.

Expressions of MDM2 and VEGF in Osteosarcoma Tissue and Clinical Significances

Expression of VEGF and PCNA and Microvessel Density in Osteosarcoma

Expression of survivin and its relationship with vascular endothelial cell growth factor in osteosarcoma

Relationship of MMP-7,MMP-9 and MMP-10 Expressions with Invasion and Metastasis in Osteosarcomas and Its Clinical Significance

Expression of HIF-1α and Its Relationship with Angiogenesis in Osteosarcoma

Expression of BMP-2,OPN and VEGF and Their Clinical Significance in Osteosarcoma with Lung Metastasis

Correlation Between Pathological Features and Protein Expressions of TfR1, VEGF and MMP-9 in Patients with Osteosarcoma

The Expression and Clinical Significance of Matrix Metalloproteinase-9 and Vascular En-Dothelial Growth Factor in Ovarian Cancer Tissue

Expression and Clinical Significance of Matrix Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinase 1 in Osteosarcoma

Relationship of the Expression of HIF-1α and GLUT-1 with Angiogenesis in Osteosarcoma

EXPRESSION OF RHOC AND MMP-9 IN OSTEOSARCOMA AND ITS CLINICOPATHOLOGICAL SIGNIFICANCE

Co-expression of CD44v6 and MMP2 predicts lung metastasis and unfavorable prognosis in osteosarcoma

The Expression of VEGF and MMP-9 in Gastric Carcinoma and Their Roles in Invasion and Metastasis

Expression and Significance of VEGF and MMP-9 in Gastric Carcinoma

Expression of matrix metalloproteinase-9 and vascular endothelial growth factor in gastric cancer and its correlation with invasion and metastasis

Expressions of RECK mRNA and MMP-2 mRNA in osteosarcoma and their clinical significance

Manifestation of vasculogenic mimicry in osteosarcoma and its prognostic significance

Expression and Clinical Significance of MMP-10 and VEGF in Renal Cell Carcinoma